India's Suven Life Sciences off lows on advancing drug trial after positive results

Suven Life Sciences

03/10/2024 08:30

** Shares of Suven Life Sciences  SUVP.NS  cut losses, last
down 0.3% to 145.64 rupees
    ** Co says it will advance depressive disorder treatment
drug into next phase of clinical study expected to start in
2025, after presenting positive drug trial results at a
conference in Chicago
    ** Stock was down 2.7% before the announcement
    ** SUVP up ~79% YTD vs ~28% rise in rival Syngene
International  SYNN.NS 

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))